Latest Biotechnology, Pharmaceutical and Healthcare News from Proactive Investors

13:37 EDT 19th August 2018 | BioPortfolio

Here are the most relevant search results for "Proactive Investors" found in our extensive news archives from over 250 global news sources.

More Information about Proactive Investors on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Proactive Investors for you to read. Along with our medical data and news we also list Proactive Investors Clinical Trials, which are updated daily. BioPortfolio also has a large database of Proactive Investors Companies for you to search.

Showing News Articles 1–25 of 1,600+ from Proactive Investors

Friday 17th August 2018

Cannabis stocks in Canada recover after a whirlwind week; Canopy Growth up 8.6% on Friday

Cannabis stocks stabilized in Canada on Friday after doing significant drops and bumps this week on the back of a host of news in the country that is nearing recreational legalized marijuana in Oct.

Small-Cap Snapshot: Investors smile as Evolus wins approval to market its Botox-like treatment in Canada

Small cap names on the move are: Evolus Inc (NASDAQ:EOLS), Zoë's Kitchen Inc (NYSE:ZOES), America’s Car-Mart Inc (NASDAQ:CRMT), Zion Oil & Gas Inc (NASDAQ:ZN). 

Collagen Solutions looks to have put last year’s difficulties behind it with strong start to current year

Since reporting its full-year results on July 10, the AIM-listed shares have rallied over 38% in the past month to 3.65p currently, taking year-to-date gains to a third

Arix sees significant potential as it ups stake in cancer treatment developer Artios

Jonathan Tobin, investment director at Arix Bioscience Plc (LON:ARIX), discusses with Proactive's Andrew Scott their decision to increase their stake and in doing so becoming the largest shareholder in Artios Pharma. Artios is developing DNA damage response technology to treat cancer. Tobin says the new funds will help Artios advance its portfolio of  small molecule DDR programmes - inc...

Tumour Trace device 'just makes sense' - Lancor's chief medical officer

Lancor Scientific's chief operating officer Gopal Rao and chief medical officer Roland Schlesinger discuss with Proactive Investors some of the upcoming milestones for their Tumour Trace technology. Roland Schlesinger's a specialist in health technology assessment - essentially analysing pharmaceuticals or medical technologies for efficiency and efficacy. ''The great thing about the technolo...

Callitas Health ropes in BFS Innovations and Pure Leaf Group to launch CannaStrips globally

The Cincinnati-based company has developed a novel delivery technology that helps achieve more precise dosing — a tricky undertaking when it comes to medical cannabis

Sensyne Health makes solid start on AIM debut

Sensyne issued shares at 175p as part of its initial public offering, and those shares are already trading at 187.5p – a gain of 7%

Antares stock surges on FDA approval of VIBEX auto injector

Auto injector drug device combination approved by the FDA

Motif Bio to present iclaprim data at microbiology conference in Portugal next month

Chief medical officer David Huang will give a presentation on Motif’s next generation antibiotic on September 5 at the conference, which is being held in Lisbon

Thursday 16th August 2018

SkinBioTherapeutics achieves 'commercial levels of scale-up' of its technology

Dr Cath O'Neill, chief executive of SkinBioTherapeutics PLC (LON:SBTX), tells Proactive's Andrew Scott their recent work's been focusing on turning the technology into a real commercial proposition. ''We've made some very good progress to that end .. what we've been able to report this morning is that we've achieved commercial levels of scale-up and we've been able to freeze-dry the technology...

Small-Cap Snapshot: Evoke Pharma is on the rise after US regulators say they will review its drug Gimoti

Small cap names on the move today are: Evoke Pharma Inc (NASDAQ:EVOK), Ferroglobe PLC (NASDAQ:GSM), Pain Therapeutics Inc (NASDAQ:PTIE), JC Penney Inc (NYSE:JCP). 

CryptoCann™ Report: Start-up Sfox wants to simplify crypto trading for institutional investors; Nutritional High expands its edibles portfolio

Crypto trading platform Sfox has raised a total of US$23mln through venture capital firms and crypto investors

Woodford will be hoping Sensyne Health can provide some remedy to his flagging funds

The star fund manager has endured a difficult time with his various funds since setting up his own firm in 2014; can Sensyne Health, which joins AIM tomorrow, provide some respite?

Summit Therapeutics awarded additional US$12mln under contract with US BARDA

The AIM-listed group said the US Biomedical Advanced Research and Development Authority funds will support the Phase 3 development programme for ridinilazole, the company's precision new mechanism antibiotic for the treatment of C. difficile infection

AstraZeneca valuation 'too stretched', says Jefferies as it downgrades the stock

Jefferies cut its rating on AstraZeneca to ‘hold’ from ‘buy’ but raised its target price to 6,200p from 5,942p

Cambian agrees to be taken over by CareTech for up to £372mln

Analysts at Liberum believe the value of Cambian is "meaningfully greater" than what CareTech has offered for the firm but they see the benefits of the proposed merger

Cosmos Holdings reports strong 2Q results thanks to booming pharmaceutical sales

CEO Grigorios Siokas says aggressive sales and marketing pushed up quarterly profits

Vascular Biogenics posts 2Q earnings beat; says it has enough resources for three years

The company reports an earnings loss, but has enough resources to fund operations

Strongbridge Biopharma stock spikes after terminating offer of ordinary shares

Public offering of millions of shares called off by the biopharma company

Abzena set to bow out after agreeing £34mln deal with leading private equity house

Buyer WCAS has invested around US$9bn in companies in the healthcare sector

SkinBioTherapeutics successfully scales-up manufacturing

SkinBioTherapeutics' platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin.

Wednesday 15th August 2018

Cannabis stocks rocket upwards in Canada on the back of funding and acquisition announcements; Canopy Growth up 31%

Cannabis stocks did an about-face on Wednesday as they soared in Canada after a host of positive news, after dropping sharply Tuesday.

PreveCeutical Medical strikes licensing deal with Asterion Cannabis for three natural health products

The products in question are three natural sleep aids, named "Blissful Sleep", "Blissful Sleep Ex" and "Skullcap Serenity".

Small-Cap Snapshot: Pain Therapeutics shares rally after defying FDA rejection of lead drug

Small cap names on the move today are: Pain Therapeutics Inc (NASDAQ:PTIE), Casa Systems Inc's (NASDAQ:CASA), PetlQ Inc (NASDAQ:PETQ), Sigma Designs Inc (NASDAQ:SIGM). 

SELLAS Life Sciences' 2Q disappoints despite FDA progress with cancer therapy drug

The clinical-stage biopharma reported a net loss of US$1.26 per share, down from US$4.50 per share last year

Quick Search


News Quicklinks